Upgrades Sec Perform Outperform X

RMD ResMed

RBC Capital Mkts

$294

Initiated Overweight X

RMD ResMed

Morgan Stanley

$280

Initiated Buy X

RMD ResMed

Goldman

Initiated Neutral X

RMD ResMed

Piper Sandler

$252

Initiated Hold X

RMD ResMed

Stifel

$250

Initiated Outperform X

RMD ResMed

Robert W. Baird

$280

Downgrades Peer Perform Underperform X

RMD ResMed

Wolfe Research

$180

Downgrades Buy Hold X

RMD ResMed

Needham

Downgrades Outperform Perform X

RMD ResMed

Oppenheimer

Downgrades Buy Neutral X

RMD ResMed

Citigroup

Resumed Overweight X

RMD ResMed

KeyBanc Capital Markets

$227

Upgrades Eq-Weight Overweight X

RMD ResMed

Morgan Stanley

$180 $169

Downgrades Outperform Sec Perform X

RMD ResMed

RBC Capital Mkts

$273 $202

Upgrades Neutral Overweight X

RMD ResMed

JP Morgan

$210 $170

Downgrades Outperform Peer Perform X

RMD ResMed

Wolfe Research

Upgrades Hold Buy X

RMD ResMed

Needham

$180

Downgrades Buy Neutral X

RMD ResMed

UBS

$265 $170

Upgrades Sec Perform Outperform X

RMD ResMed

RBC Capital Mkts

$262 $284

Initiated Buy X

RMD ResMed

UBS

$290

Initiated Buy X

RMD ResMed

Mizuho

$255

Upgrades Neutral Overweight X

RMD ResMed

JP Morgan

$245

Downgrades Buy Neutral X

RMD ResMed

Citigroup

Upgrades Neutral Buy X

RMD ResMed

BofA Securities

$245 $260

Initiated Hold X

RMD ResMed

Jefferies

Upgrades Neutral Buy X

RMD ResMed

Citigroup

Downgrades Buy Outperform X

RMD ResMed

CLSA

Downgrades Buy Neutral X

RMD ResMed

Citigroup

Downgrades Overweight Neutral X

RMD ResMed

JP Morgan

Downgrades Outperform Sec Perform X

RMD ResMed

RBC Capital Mkts

$246 $252

Upgrades Sec Perform Outperform X

RMD ResMed

RBC Capital Mkts

$233 $244

Upgrades Underperform Neutral X

RMD ResMed

BofA Securities

$239 $250

Upgrades Sec Weight Overweight X

RMD ResMed

KeyBanc Capital Markets

$302

Upgrades Underperform Hold X

RMD ResMed

Jefferies

$170 $240

Downgrades Overweight Neutral X

RMD ResMed

JP Morgan

$245 $246

Initiated Underperform X

RMD ResMed

RBC Capital Mkts

$223

Downgrades Buy Neutral X

RMD ResMed

Citigroup

Initiated Neutral X

RMD ResMed

Robert W. Baird

$240

Reiterated Buy X

RMD ResMed

Needham

$229 $267

Downgrades Neutral Underperform X

RMD ResMed

BofA Securities

$216 $221

Upgrades Neutral Overweight X

RMD ResMed

JP Morgan

$206 $219

Upgrades Neutral Buy X

RMD ResMed

Citigroup

Upgrades Hold Buy X

RMD ResMed

Needham

$229

Upgrades Neutral Buy X

RMD ResMed

UBS

$122 $140

Downgrades Buy Neutral X

RMD ResMed

UBS

Upgrades Neutral Buy X

RMD ResMed

UBS

$109 $119

Upgrades Underweight Neutral X

RMD ResMed

JP Morgan

$95

Downgrades Buy Neutral X

RMD ResMed

Goldman

Downgrades Neutral Underweight X

RMD ResMed

JP Morgan

Upgrades Neutral Outperform X

RMD ResMed

Credit Suisse

Initiated Buy X

RMD ResMed

Goldman

Downgrades Buy Neutral X

RMD ResMed

Citigroup

RMD  ResMed Inc.

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.